METTL14 and urinary bladder carcinoma: In contrast, another study on bladder cancer shows that METTL14 is downregulated in bladder tumor-initiating cells (TICs), and its deletion increases TIC self-renewal and bladder tumorigenesis (Gu et al., 2019).